{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:19:42Z","timestamp":1648811982120},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2038,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/j.1478-3231.2009.02195.x","type":"journal-article","created":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T12:37:32Z","timestamp":1261571852000},"page":"161-163","source":"Crossref","is-referenced-by-count":1,"title":["Learning from the pregnane X receptor: how to fight one aggressor with two strategies"],"prefix":"10.1111","volume":"30","author":[{"given":"Christian","family":"Rust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB1","doi-asserted-by":"crossref","unstructured":"1.\u00e2\u0080\u0082 Schmucker DL , Ohta M , Kanai S , Sato Y , Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990; 12: 1216\u00e2\u0080\u009321.","DOI":"10.1002\/hep.1840120523"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB2","doi-asserted-by":"crossref","unstructured":"2.\u00e2\u0080\u0082 Beuers U , Spengler U , Zwiebel FM , et al. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992; 15: 603\u00e2\u0080\u00938.","DOI":"10.1002\/hep.1840150409"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB3","doi-asserted-by":"crossref","unstructured":"3.\u00e2\u0080\u0082 Yoon JH , Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol 2002; 37: 400\u00e2\u0080\u009310.","DOI":"10.1016\/S0168-8278(02)00209-X"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB4","doi-asserted-by":"crossref","unstructured":"4.\u00e2\u0080\u0082 Reinehr R , Becker S , Keitel V , et al. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 2005; 129: 2009\u00e2\u0080\u009331.","DOI":"10.1053\/j.gastro.2005.09.023"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB5","doi-asserted-by":"crossref","unstructured":"5.\u00e2\u0080\u0082 Rust C , Wild N , Bernt C , et al. Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent. J Biol Chem 2009; 284: 2908\u00e2\u0080\u009316.","DOI":"10.1074\/jbc.M804585200"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB6","doi-asserted-by":"crossref","unstructured":"6.\u00e2\u0080\u0082 Rodrigues CM , Fan G , Ma X , Kren BT , Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101: 2790\u00e2\u0080\u00939.","DOI":"10.1172\/JCI1325"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB7","doi-asserted-by":"crossref","unstructured":"7.\u00e2\u0080\u0082 Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 318\u00e2\u0080\u009328.","DOI":"10.1038\/ncpgasthep0521"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB8","doi-asserted-by":"crossref","unstructured":"8.\u00e2\u0080\u0082 Zucchini-Pascal N , De Sousa G , Pizzol J , Rahmani R. Pregnane X receptor activation protects rat hepatocytes against deoxycholic acid-induced apoptosis. Liver Int 2010; 30: 284\u00e2\u0080\u009397.","DOI":"10.1111\/j.1478-3231.2009.02108.x"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u00e2\u0080\u0082 Stedman C , Liddle C , Coulter S , et al. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci USA 2006; 103: 11323\u00e2\u0080\u00938.","DOI":"10.1073\/pnas.0604772103"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB10","doi-asserted-by":"crossref","unstructured":"10.\u00e2\u0080\u0082 Stedman CA , Liddle C , Coulter SA , et al. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci USA 2005; 102: 2063\u00e2\u0080\u00938.","DOI":"10.1073\/pnas.0409794102"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u00e2\u0080\u0082 Teng S , Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 2007; 151: 367\u00e2\u0080\u009376.","DOI":"10.1038\/sj.bjp.0707235"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB12","doi-asserted-by":"crossref","unstructured":"12.\u00e2\u0080\u0082 Staudinger JL , Goodwin B , Jones SA , et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001; 98: 3369\u00e2\u0080\u009374.","DOI":"10.1073\/pnas.051551698"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB13","doi-asserted-by":"crossref","unstructured":"13.\u00e2\u0080\u0082 Axon A , Cowie DE , Mann DA , Wright MC. A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: inhibition of NF-kappaB? Toxicology 2008; 246: 40\u00e2\u0080\u00934.","DOI":"10.1016\/j.tox.2007.12.008"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u00e2\u0080\u0082 Wagner M , Halilbasic E , Marschall HU , et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 2005; 42: 420\u00e2\u0080\u009330.","DOI":"10.1002\/hep.20784"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB15","doi-asserted-by":"crossref","unstructured":"15.\u00e2\u0080\u0082 Zucchini N , De Sousa G , Bailly-Maitre B , et al. Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochim Biophys Acta 2005; 1745: 48\u00e2\u0080\u009358.","DOI":"10.1016\/j.bbamcr.2005.02.005"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB16","doi-asserted-by":"crossref","unstructured":"16.\u00e2\u0080\u0082 Lavrik IN , Golks A , Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2665\u00e2\u0080\u009372.","DOI":"10.1172\/JCI26252"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB17","doi-asserted-by":"crossref","unstructured":"17.\u00e2\u0080\u0082 EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237\u00e2\u0080\u009367.","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB18","doi-asserted-by":"crossref","unstructured":"18.\u00e2\u0080\u0082 Bachs L , Pares A , Elena M , Piera C , Rodes J. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992; 102: 2077\u00e2\u0080\u009380.","DOI":"10.1016\/0016-5085(92)90335-V"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB19","doi-asserted-by":"crossref","unstructured":"19.\u00e2\u0080\u0082 Stojakovic T , Putz-Bankuti C , Fauler G , et al. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology 2007; 46: 776\u00e2\u0080\u009384.","DOI":"10.1002\/hep.21741"},{"key":"10.1111\/j.1478-3231.2009.02195.x-BIB20","doi-asserted-by":"crossref","unstructured":"20.\u00e2\u0080\u0082 Hempfling W , Grunhage F , Dilger K , et al. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 2003; 38: 196\u00e2\u0080\u0093202.","DOI":"10.1053\/jhep.2003.50266"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02195.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2009.02195.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:23:30Z","timestamp":1625664210000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02195.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02195.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}